Skip to main content

FibroBiologics, Inc.

FBLG
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001958777

No open-market purchases or sales by FibroBiologics, Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $269.6K in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding FibroBiologics, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of FBLG: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders5955−4
Shares5.96M5.39M−566.6K (−9.5%)
Value$3.75M$2.93M−$812.8K (−21.7%)

New holders (9)

Institutions that held FibroBiologics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to FBLG in Q3 2025
InstitutionSharesValue% of portfolio
Landscape Capital Management, L.L.C.350,000$191.2K0.01%
GTS Securities LLC308,661$168.5K0.01%
Renaissance Technologies LLC59,800$32.7K0.00%
Global Assets Advisory, LLC10,700$5.84K0.00%
CWA Asset Management Group, LLC10,000$5.46K0.00%
Runnymede Capital Advisors, Inc.10,000$5.46K0.00%
Optiver Holding B.V.26$140.00%
SRS Capital Advisors, Inc.2$10.00%
Luminus Management LLC26,629––

Sold out (13)

Institutions that held FibroBiologics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of FBLG in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Susquehanna International Group, LLP106,100$66.0K
Jane Street Group, LLC96,110$59.8K
Marshall Wace, LLP78,618$48.7K
Y-Intercept (Hong Kong) Ltd59,539$37.0K
AQR Capital Management LLC52,217$32.5K
XTX Topco Ltd45,945$28.6K
Bridgeway Capital Management, LLC40,000$24.9K
Point72 Asia (Singapore) Pte. Ltd.16,494$10.3K
Hantz Financial Services, Inc.8,000$5.00K
Cubist Systematic Strategies, LLC1,844$1.15K
Clearstead Advisors, LLC202$126
Citigroup Inc171$106
Essential Partners LLC12$7